-
公开(公告)号:US12102608B2
公开(公告)日:2024-10-01
申请号:US17825260
申请日:2022-05-26
申请人: EPITECH GROUP S.P.A.
IPC分类号: A61K31/164 , A23L33/115
CPC分类号: A61K31/164 , A23L33/115
摘要: A composition of acylethanolamides is obtained from olive oil fatty acids and is used in treating neuroinflammation. The acylethanolamide complex includes (weight percentages):
oleoylethanolamide (OEA) C18:1
60-65%
palmitoylethanolamide (PEA) C16:0
5-20%
linoleylethanolamide (LEA) C18:2
5-20%
stearoylethanolamide (SEA) C18:0
1-2%
palmitoylethanolamide (POEA) C16:1
0.1-0.8%
myristoylethanolamide (MEA) C14:0
0.02-0.15%
mixture of glycerides
4-6%
glycerol
6-8%.
A method obtains the acylethanolamide complex and formulations contain the acylethanolamide complex.-
公开(公告)号:US20220304954A1
公开(公告)日:2022-09-29
申请号:US17213856
申请日:2021-03-26
申请人: Epitech Group S.p.A.
发明人: Francesco Della Valle , Maria Federica Della Valle , Gabriele Marcolongo , Giuliano Claps , Chiara Gomiero , Vito Safina
摘要: The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.
-